Suzhou Bonsmile Medical Technology Co., Ltd. announced that it expects to receive funding from Lepu Medical Technology Co., Ltd.
July 13, 2021
Share
Suzhou Bonsmile Medical Technology Co., Ltd. announced that it will receive funding in an equity round on July 14, 2021. The transaction will include participation from Lepu Medical Technology (Beijing) Co., Ltd. The transaction has been approved in the 21st meeting of the 5th board of directors of the investor and does not need to be submitted to its shareholders. Post the closing of capital increase and equity transfer, investor will hold 68.4318% stake in the company.
Lepu Medical Technology (Beijing) Co., Ltd. specialized in the design, manufacture and marketing of medical devices and equipment. The group is also involved in the development and manufacturing of active pharmaceutical ingredients. Net sales break down by activity as follows:
- sale of medical devices and instruments (57.9%): primarily for cardiovascular interventions, cardiac surgery, cardiac rhythm management, anesthesia, intensive care, in vitro diagnostics and general surgery;
- sale of active pharmaceutical ingredients (30.6%): for the manufacturing of pharmaceutical products in the fields of cardiovascular diseases, infectious diseases, oncology, central nervous system disorders, etc.;
- sale of digital health and hospital network management solutions (11.6%).
China accounts for 64.7% of net sales.